Jupiter Neurosciences Received Notice of Delisting
Less than 1 min read
On August 27, 2026, Nasdaq notified the company that it determined to delist its common stock from The Nasdaq Capital Market after the company failed to regain compliance with Listing Rule 5550(b)(2) requiring at least $35 million market value of listed securities. The company intends to appeal and seek a hearing, which is expected to stay further action pending a decision, but there is no assurance of success.
Original SEC Filing: JUPITER NEUROSCIENCES, INC. [ JUNS ] - 8-K - Aug. 28, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.